Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC) Meeting Abstract


Authors: Wolpin, B. M.; O'Reilly, E. M.; Ko, Y.; Blaszkowsky, L. S.; Rarick, M. U.; Rocha Lima, C. M. S.; Ritch, P. S.; Chan, E.; Spratlin, J. L.; Macarulla, T.; McWhirter, E.; Pezet, D.; Lichinitser, M.; Roman, L. D.; Hartford, A.; Jackson, L.; Vincent, M.; Reyno, L. M.; Hidalgo, M.
Abstract Title: Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880300442
PROVIDER: wos
DOI: 10.1200/jco.2011.29.15_suppl.4031
Notes: Meeting Abstract: 4031 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly